Home > Journals > International Angiology > Past Issues > International Angiology 2021 August;40(4) > International Angiology 2021 August;40(4):297-305



Publishing options
To subscribe
Submit an article
Recommend to your librarian


Publication history
Cite this article as


ORIGINAL ARTICLE  CAROTID DISEASE Editor’s choice • Free accessfree

International Angiology 2021 August;40(4):297-305

DOI: 10.23736/S0392-9590.21.04662-9


language: English

Carotid artery stenting in patients with chronic internal carotid artery occlusion

Piotr MYRCHA 1, 2 , Peter GLOVICZKI 3

1 Department of General and Vascular Surgery, Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland; 2 Department of General, Vascular and Oncological Surgery, Masovian Brodnowski Hospital, Warsaw, Poland; 3 Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN, USA

BACKGROUND: The risk of ischemic stroke in patients with chronic total occlusion (CTO) of the internal carotid artery (ICA) on best medical treatment has been estimated to be 5.5% per year. The purpose of this study was to assess early and mid-term outcome of patients who underwent an attempt at transfemoral carotid artery stenting (CAS) for CTO of the ICA.
METHODS: Clinical data of symptomatic patients who underwent attempt at CAS for CTO of the ICA between January 1, 2010 and July 1, 2020 were retrospectively reviewed. Clinical success, perioperative and mid-term stroke and death rates were recorded. Descriptive statistics were used.
RESULTS: There were 27 patients, 14 females, 13 males, with a mean age of 66.8 years, range: 57 to 79. All patients had symptoms within 6 months prior to the procedure. 16 had ipsilateral stroke at a mean of 2.8 months, ranges: 1.5-4 months, two had transient ischemic attack (TIA), at 1 week and at 6 months, one had amaurosis fugax at one week, two had chronic ocular ischemia and six had chronic cerebral hypoperfusion. Technical success was 52% (14/27). One patient developed a minor reversible stroke (1/27, 3.7%) there was no early death, for an overall 30-day stroke and death rate of 3.7% (1/27). Two patients had perioperative TIAs. Among 14 patients with successful CAS (group A) one had minor, reversible ipsilateral stroke during a follow-up of 29 months (range: 4-112), two had contralateral stroke. There was no death. One patient developed asymptomatic stent occlusion, three had asymptomatic in-stent restenosis >50%, two had reinterventions. Among patients with unsuccessful attempt at CAS (group B), 31% (4/13) had stroke at 4, 10, 14 and 22 months, respectively. One stroke patient died at 10 months.
CONCLUSIONS: Transfemoral CAS of symptomatic patients with CTO of the ICA was feasible in half of the patients, with no mortality or major stroke, for an overall early stroke/death rate of 3.7%. Since one third of the patients with unsuccessful stenting developed stroke during follow-up, further studies to investigate the safety, efficacy and durability of CAS for CTO of the ICA are needed.

KEY WORDS: Stents; Endovascular procedures; Carotid artery, internal

top of page